Skip to main content
Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer

Fig. 2

Kaplan-Meier curves by treatment arm; advanced or metastasized lung cancer. Kaplan–Meier curves for survival by treatment arm during total observation period (55 months, 4.6 years) and median survival in months for patients with advanced or metastasized lung cancer. ICM, immune checkpoint inhibitor nivolumab, ICM-VA, therapy with immune checkpoint inhibitors and concomitant Viscum album L.; CI, confidence interval. *based on log rank test

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us